Guidelines for the Intravenous Application of Recombinant Tissue-type Plasminogen Activator (Alteplase), the Second Edition, October 2012: A Guideline From the Japan Stroke Society
Authors:
- Kazunori ToyodaKTKazunori Toyoda
- Teruyuki HiranoTHTeruyuki Hirano
- Kazumi KimuraKKKazumi Kimura
- Rei KondoRKRei Kondo
- Etsuro MoriEMEtsuro Mori
- Jyoji NakagawaraJNJyoji Nakagawara
- Nobuyuki SakaiNSNobuyuki Sakai
- Yoshiaki ShiokawaYSYoshiaki Shiokawa
- Norio TanahashiNTNorio Tanahashi
- Masahiro YasakaMYMasahiro Yasaka
- Yasuo KatayamaYKYasuo Katayama
- 1 July 2013
- journal article
- practice guideline
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 22 (5) , 571-600
Abstract
No abstract availableKeywords
This publication has 153 references indexed in Scilit:
- Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trialThe Lancet, 2012
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet, 2012
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe Lancet, 2012
- Too Good to Treat? Outcomes in Patients Not Receiving Thrombolysis Due to Mild Deficits or Rapidly Improving SymptomsInternational Journal of Stroke, 2011
- Intravenous Thrombolysis in Ischemic Stroke Patients with Intracranial Neoplasms: Two Cases and a Literature ReviewCase Reports in Medicine, 2011
- Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report: Figure 1BMJ Case Reports, 2009
- Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled studyThe Lancet Neurology, 2009
- Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of OnsetStroke, 2006
- Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke CentersStroke, 2006
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996